Sponsor or institution
Clinical trials and research at Strand Therapeutics Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Strand Therapeutics Inc. that are recruiting, at sites in 2 countries (most in Australia (2), United States (2)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
STX-003 in advanced solid tumors given by IV, alone or with pembrolizumab
This study tests STX-003, given by IV, to see if it is safe and potentially effective for patients with advanced solid tumors, either alone or with pembrolizumab.
-
Injecting STX-001 into tumors for advanced solid cancers
This study is testing a new treatment called STX-001, injected directly into tumors, to see if it can help people with advanced solid cancers like triple-negative breast cancer and melanoma, both on its own and with another immunotherapy drug.
Quick answers
How many clinical trials run by Strand Therapeutics Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Australia (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.